Longitudinal Tumor-informed Circulating Tumor DNA Status Predicts Disease Upstaging and Poor Prognosis for Patients Undergoing Radical Cystectomy

Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma

Dean F. Bajorin, J. Alfred Witjes, Jürgen E. Gschwend et al. · New England Journal of Medicine · 2021 · 1K citations · Full text

Medicine, Oncology, Surgery +17

Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline

Sam S. Chang, Bernard H. Bochner, Roger Chou et al. · The Journal of Urology · 2017 · 940 citations · Full text

Medicine, Oncology, Radiation Oncology +13

Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial

Dipen J. Parekh, Isildinha M. Reis, Erik P. Castle et al. · The Lancet · 2018 · 763 citations

Medicine, Surgery, Urology +16

ctDNA guiding adjuvant immunotherapy in urothelial carcinoma

Thomas Powles, Zoe J. Assaf, Nicole N. Davarpanah et al. · Nature · 2021 · 604 citations

Medicine, Oncology, Urology +12

Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder Carcinoma

Emil Christensen, Karin Birkenkamp‐Demtröder, Himanshu Sethi et al. · Journal of Clinical Oncology · 2019 · 545 citations · Full text

Medicine, Oncology, Urology +17